featured
Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer Unsuitable for Cisplatin-Based Chemoradiation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: